CLEC2D Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag)
-
- Antigène Voir toutes CLEC2D Protéines
- CLEC2D (C-Type Lectin Domain Family 2, Member D (CLEC2D))
- Type de proteíne
- Recombinant
- Attributs du protein
- Transcript Variant 2
-
Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette CLEC2D protéine est marqué à la Myc-DYKDDDDK Tag.
- Application
- Antibody Production (AbP), Standard (STD)
- Attributs du produit
-
- Recombinant human CLEC2D (transcript variant 2) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- Pureté
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
- Top Product
- Discover our top product CLEC2D Protéine
-
-
- Indications d'application
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Commentaires
-
The tag is located at the C-terminal.
- Restrictions
- For Research Use only
-
- Concentration
- 50 μg/mL
- Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
- Stock
- -80 °C
- Stockage commentaire
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Antigène
- CLEC2D (C-Type Lectin Domain Family 2, Member D (CLEC2D))
- Autre désignation
- Clec2d (CLEC2D Produits)
- Synonymes
- CLAX Protein, LLT1 Protein, OCIL Protein, Clr-b Protein, Clrb Protein, Ocil Protein, Clec2d5 Protein, CLEC2D Protein, C-type lectin domain family 2 member D Protein, C-type lectin domain family 2, member d Protein, C-type lectin domain family 2, member D Protein, CLEC2D Protein, Clec2d Protein
- Sujet
- This gene encodes a member of the natural killer cell receptor C-type lectin family. The encoded protein inhibits osteoclast formation and contains a transmembrane domain near the N-terminus as well as the C-type lectin-like extracellular domain. Several alternatively spliced transcript variants have been identified for this gene.
- Poids moléculaire
- 22.1 kDa
- NCBI Accession
- NP_001004419
- Pathways
- Regulation of Leukocyte Mediated Immunity
-